Breakthrough in Fetal Disease Study: Viable Cells in Amniotic Fluid Offer New Research Avenues
March 4, 2024
Researchers in the U.K. have made a significant discovery in fetal health research by identifying viable epithelial cells in amniotic fluid, capable of growing into organoids representing organs such as the lung, kidney, and small intestines. This advancement opens new possibilities for studying and diagnosing congenital fetal diseases without directly accessing the fetus. Traditionally, fetal organoid models have relied on postmortem tissue, surrounded by ethical controversies. The new method, utilizing cells from amniotic fluid collected during amniocentesis, sidesteps these issues and allows for examining diseases and developing personalized medicine approaches. This research, promising for prenatal diagnostics and therapy monitoring, signifies a significant leap forward in non-invasive fetal health studies, potentially transforming our understanding and treatment of congenital conditions.
To read more, click here.
[Source: STAT, March 4th, 2024]
